Replies to post #385 on Acorda Therapeutics Inc (fka ACORQ)

[Michel]

"Acorda, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $53.09 million for the quarter ended September 2020, surpassing the Zacks Consensus Estimate by 80.64%. This compares to year-ago revenues of $47.72 million. The company has topped consensus revenue estimates three times over the last four quarters."